SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-024571
Filing Date
2021-06-17
Accepted
2021-06-17 21:13:46
Documents
2
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6713
2 EX-24 DOCUMENT attachment1.htm EX-24 4043
  Complete submission text file 0000899243-21-024571.txt   12169
Mailing Address C/O PHARMACYCLICS INC 995 E ARQUES AVE SUNNYVALE CA 94085-4521
Business Address
RENSCHLER MARKUS MD (Reporting) CIK: 0001217598 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40499 | Film No.: 211026882

Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Issuer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations